固定剂量氯胺酮用于院前高活动性谵妄伴严重激越的管理
研究回顾四个急救机构院前使用氯胺酮的132例记录,纳入60例因高活动性谵妄伴严重激越接受起始250 mg固定剂量氯胺酮的成人,允许无效时追加250 mg。患者中位体重80 kg(范围50–176 kg)。院前无患者被急救人员插管,1例仅需吸痰,3例需球囊面罩呼吸支持;6例(10%)在急诊科插管,包括上述3例(5%)及另外3例(5%)在急诊科进一步镇静后插管,6例插管者均以大脑功能分类(CPC)1分出院。250 mg起始剂量折合体重剂量(OR 2.62,CI 0.67–10.22)及院前总剂量(含12例接受第二剂者,OR 0.74,CI 0.27–2.03)与插管需求均无显著关联。仅12例(20%)接受第二剂,均未发生不良事件,提示起始250 mg对80%患者有效;4例院前不良事件可能与氯胺酮有关。全部60例存活出院。
要点
- 院前对高活动性谵妄伴严重激越成人起始固定250 mg氯胺酮,仅12例(20%)需追加第二剂250 mg,提示起始剂量对80%患者有效。
- 院前无患者被急救人员插管,1例仅需吸痰,3例(5%)需球囊面罩呼吸支持;急诊科插管6例(10%),包括上述3例及另外3例(5%)进一步镇静后插管。
- 6例插管患者均以CPC 1分存活出院,全部60例存活出院。
- 250 mg起始剂量折合体重剂量(OR 2.62,CI 0.67–10.22)及院前总剂量(OR 0.74,CI 0.27–2.03)与插管需求无显著关联。
- 作者指出250 mg固定剂量并非对所有患者都相当于>5 mg/kg体重剂量,需进一步研究最佳单次给药剂量。
适用人群与场景
- 四个急救机构院前环境中,因临床体征符合高活动性谵妄伴严重激越(HDSA)而接受按常备医嘱给予250 mg氯胺酮的成人患者。
诊断标准与关键阈值
- 纳入标准:按常备医嘱接受250 mg氯胺酮、成人、临床体征符合高活动性谵妄伴严重激越(HDSA)。
- 方案允许若首剂无效可再给第二剂250 mg氯胺酮。
处置流程与药物剂量
- 按常备医嘱给予起始250 mg固定剂量氯胺酮;若首剂无效,方案允许追加第二剂250 mg。
- 对250 mg起始剂量及院前总剂量均进行体重剂量折算和不良事件分析。
红旗征与不能漏的情况
- 院前不良事件中,1例需吸痰,3例(5%)需球囊面罩呼吸支持并随后在急诊科插管。
研究设计与关键结果
- 回顾四个急救机构132例记录,60例符合纳入标准;患者中位体重80 kg(范围50–176 kg)。
- 院前无患者被急救人员插管,1例仅需吸痰,3例需球囊面罩呼吸支持;急诊科插管6例(10%),包括上述3例(5%)及另外3例(5%)在急诊科进一步镇静后插管;6例插管者均以CPC 1分出院。
- 仅12例(20%)接受第二剂250 mg氯胺酮,均未发生不良事件;提示起始250 mg对80%患者有效。
- 发现4例院前不良事件可能与氯胺酮给药有关。
- 250 mg起始剂量折合体重剂量(OR 2.62,CI 0.67–10.22)及院前总剂量(含12例接受第二剂者,OR 0.74,CI 0.27–2.03)与插管需求均无显著关联。
- 全部60例患者存活出院。
证据类型、等级与局限
- 证据类型:急救机构病历回顾性研究。
- 局限:作者指出250 mg固定剂量并非对所有患者都相当于>5 mg/kg体重剂量;需进一步研究以确定高活动性谵妄伴严重激越患者氯胺酮的最佳单次给药剂量、标准化固定剂量方案是否简化给药,以及固定剂量是否减少剂量错误。
对床旁实践的改变
- 作者认为,需进一步研究以确定高活动性谵妄伴严重激越患者氯胺酮的最佳单次给药剂量、标准化固定剂量方案是否简化给药,以及固定剂量是否减少剂量错误。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Patients exhibiting signs of hyperactive delirium with severe agitation (HDSA) may require sedating medications for stabilization and safe transport to the hospital. Determining the patient's weight and calculating the correct weight-based dose may be challenging in an emergency. A fixed dose ketamine protocol is an alternative to the traditional weight-based administration, which may also reduce dosing errors. The objective of this study was to evaluate the frequency and characteristics of adverse events following pre-hospital ketamine administration for HDSA.
METHODS: Emergency Medical Services (EMS) records from four agencies were searched for prehospital ketamine administration. Cases were included if a 250 mg dose of ketamine was administered on standing order to an adult patient for clinical signs consistent with HDSA. Protocols allowed for a second 250 mg dose of ketamine if the first dose was not effective. Both the 250 mg initial dose and the total prehospital dose were analyzed for weight based dosing and adverse events.
RESULTS: Review of 132 cases revealed 60 cases that met inclusion criteria. Patients' median weight was 80 kg (range: 50-176 kg). No patients were intubated by EMS, one only requiring suction, three required respiratory support via bag valve mask (BVM). Six (10%) patients were intubated in the emergency department (ED) including the three (5%) supported by EMS via BVM, three (5%) others who were sedated further in the ED prior to requiring intubation. All six patients who were intubated were discharged from the hospital with a Cerebral Performance Category (CPC) 1 score. The weight-based dosing equivalent for the 250 mg initial dose (OR: 2.62, CI: 0.67-10.22) and the total prehospital dose, inclusive of the 12 patients that were administered a second dose, (OR: 0.74, CI: 0.27, 2.03), were not associated with the need for intubation.
CONCLUSION: The 250 mg fixed dose of ketamine was not >5 mg/kg weight-based dose equivalent for all patients in this study. Although a second 250 mg dose of ketamine was permitted under standing orders, only 12 (20%) of the patients were administered a second dose, none experienced an adverse event. This indicates that the 250 mg initial dose was effective for 80% of the patients. Four patients with prehospital adverse events likely related to the administration of ketamine were found. One required suction, three (5%) requiring BVM respiratory support by EMS were subsequently intubated upon arrival in the ED. All 60 patients were discharged from the hospital alive. Further research is needed to determine an optimal single administration dose for ketamine in patients exhibiting signs of HDSA, if employing a standardized fixed dose medication protocol streamlines administration, and if the fixed dose medication reduces the occurrence of dosage errors.
参考来源
- O'Brien MC, Kelleran KJ, Burnett SJ, et al. Fixed dose ketamine for prehospital management of hyperactive delirium with severe agitation. Am J Emerg Med. 2024. PMID: 38626643. doi:10.1016/j.ajem.2024.04.011
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。